Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05177562Recruiting

Reproductive Endocrinology Oxford Study (RepOx)

Role: collaborator

NCT02398162Completed

Scrub Typhus Pediatric Immunology Study

Role: collaborator

NCT00493363Not ApplicableCompleted

Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia

Role: collaborator

NCT01374009Terminated

H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009

Role: collaborator

All 4 trials loaded